| 摘要 |
Soft tissue implants (e.g., breast, pectoral, chin, facial, lip, and nasal implants) are used in combination with an anti-scarring drug combination in order to inhibit scarring that may otherwise occur when the implant is placed within an animal.
|
| 申请人 |
COMBINATORX, INCORPORATED;ANGIOTECH INTERNATIONAL AG;HUNTER, WILLIAM, L.;TOLEIKIS, PHILIP, M.;GRAVETT, DAVID, M.;GRAU, DANIEL, S.;BORISY, ALEXIS;KEITH, CURTIS, T.;AUSPITZ, BNJAMIN, A.;NICHOLS, M., JAMES;JOST-PRICE, EDWARD, ROYDON;SERBEDZIJA, GEORGE, N. |
发明人 |
HUNTER, WILLIAM, L.;TOLEIKIS, PHILIP, M.;GRAVETT, DAVID, M.;GRAU, DANIEL, S.;BORISY, ALEXIS;KEITH, CURTIS, T.;AUSPITZ, BNJAMIN, A.;NICHOLS, M., JAMES;JOST-PRICE, EDWARD, ROYDON;SERBEDZIJA, GEORGE, N. |
